Larvol Delta - Acepodia-Announces-First-Patient-Dosed-in-Phase-1-Clinical-Trial-of-ACE1831-an-AntiCD20-Armed-Allogeneic-Gamma-Delta-Tcell-Therapy-in-Development-to-Treat-Patients-with-NonHodgkins-Lymphoma

ACE1831 - Acepodia

https://www.prnewswire.com/news-releases/acepodia-announces-first-patient-dosed-in-phase-1-clinical-trial-of-ace1831-an-anti-cd20-armed-allogeneic-gamma-delta-t-cell-therapy-in-development-to-treat-patients-with-non-hodgkins-lymphoma-301830957.html

May 22, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next